Diagnostic Bioconjugates

Diagnostic Detection through Immunoconjugation

Bio-Synthesis, a leading biology CRO, focuses exclusively on early drug discovery and development services. Bio-Synthesis provides a comprehensive portfolio of highly specific bioconjugates to diagnostic and medical imaging companies. Relying on our state-of-the art manufacturing facility and scientists with extensive experience in chemical biology, we have delivered to our clients thousands of nucleic acid or protein based detection reagents that are supported and validated by our bioanalytical laboratory. From project scope analysis and problem solving proposal, complex biopolymer production, and assay development, we strive with competence and confidence to meet your demand for creating novel conjugates that can be quickly and cost-effectively added to your value chain. Bio-Synthesis is your partner in diagnostic innovation.

• Design and development of conjugate strategy
• Proof of concept through pilot run
• Development of purification and analytical method
• Assay validation
• Scale up production
• Technology Transfer

Service Portfolios:

• Peptide-macrocyclic metal conjugates
• Peptide-nitrocellulose immobilization
• Antibody-luminex bead conjugates
• Oligonucleotide-luminex bead conjugates
• Oligonucleotide glass slide printing
• Oligonucleotide-agarose conjugates
• Enzyme-based bioconjugates
• Epitope-based detection
• Microsphere and nanosphere conjugates
• Redox-active probes

To obtain further information regarding your diagnostic bioconjugation project, contact our National Customer Services Center at 800.227.0627 or contact us online with each inquiry to assist in meeting customer specifications.